MISSISSAUGA, Ontario--(BUSINESS WIRE)--Biogen Idec Canada Inc today announced AVONEX ® PEN ™ is now available for patients with relapsing multiple sclerosis (MS) and patients with a single ...

CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

Denver, CO – June 2, 2008 – Results from an analysis assessing the differences in health benefits costs (HBCs) and lost time among employees suffering from multiple sclerosis (MS) being treated with ...

CAMBRIDGE, MA – Sept. 11, 2009 – Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

Biogen Idec’s multiple sclerosis drug Avonex can cause severe liver damage, U.S. regulatory officials and the company warned Wednesday, the latest in a series of blows to MS patients. Subscribe to ...

ZEPOSIA demonstrated a relative reduction in ARR versus Avonex of 48% at one year and 38% at two years (absolute ARR of 0.18 versus 0.35 and 0.17 versus 0.28, respectively). 1,2,3 Treatment with ...

The price you pay for Avonex may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Biogen Idec (Nasdaq: BIIB), a biotechnology company best ...

Avonex (interferon beta-1a) may not be safe to use while pregnant or breastfeeding. Certain factors may determine whether you should use the drug during this time. »Learn more about Avonex, including ...

(Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced the appointment of Michael "Mike" W. Bonney, a highly ...